RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production

Area of Science:

• Immunology
• Molecular Biology
• Virology

Background:

• Viral infections pose a global health challenge, necessitating novel antiviral therapies.
• Type I interferons (IFN-I) are critical for innate antiviral immunity, rapidly produced upon viral recognition by pathogen recognition receptors (PRR).
• The precise intracellular signaling pathways downstream of PRR activation require further elucidation.

Purpose of the Study:

• To investigate the role of CASP2 and RIPK1 domain-containing adaptor with death domain (CRADD/RAIDD) in type I interferon production.
• To elucidate the molecular mechanisms by which RAIDD influences the innate immune response to viral infections.

Main Methods:

• Western blot analysis to detect protein interactions.
• shRNA-mediated lentiviral knockdown to assess gene function.
• Immunoprecipitation to identify molecular binding partners.
• IFN-I driven dual luciferase assays to measure transcriptional activity.

Main Results:

• RAIDD was found to interact with interferon regulatory factor 7 (IRF7) and its kinase IKKε.
• RAIDD deficiency significantly reduced type I IFN activation mediated by IKKε and IRF7.
• Specific domains of RAIDD (CARD and DD) were shown to be critical for mediating IKKε and IRF7-induced IFN-I activation.

Conclusions:

• RAIDD acts as a crucial adaptor molecule in the type I interferon signaling pathway.
• RAIDD facilitates the interaction between IKKε and IRF7, ensuring efficient type I interferon expression.
• Understanding RAIDD's function provides insights into innate antiviral immunity and potential therapeutic targets.